← Leaderboards
Ruwan Gunaratne
Duke University
$122,940
Attributed
$122,940
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49K · FY2015–17$50K$37.5K$25K$12.5K$0
'15
'16
'17
Funding mix
By agency
NIH$122,940 · 1
By mechanism
F30$122,940 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Thomas L Ortel$32,805,539
- Kevin M Watt$9,629,862
- William H Kane$4,042,669
- Richard Clinton Becker$11,111,515
- Douglas Brock Cines$21,888,352
Others in their field
Top investigators on “Active Sites”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$546,695,551
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Albert Lazzarini · California Institute Of Technology$372,427,285
Research focus
Active SitesConsumptionAngioplastyAnticoagulantsCombinatorialAnticoagulationAntidotesAptamerAptamer TechnologyBaseAnticoagulant TherapyAffinityBiochemicalBloodBlood CoagulationBlood Coagulation FactorCardiacCardiac Surgery ProceduresCardiopulmonary BypassCatalytic DomainClotting EnzymeCoagulation ProcessCofactorDesign
Grant awards (3)
Studying Anticoagulant Synergy of Factor Xa Aptamer and Catalytic Site Inhibitors$49,044
F30 · FY2017 · HL · contact PI
Studying Anticoagulant Synergy of Factor Xa Aptamer and Catalytic Site Inhibitors$37,176
F30 · FY2016 · HL · contact PI
Studying Anticoagulant Synergy of Factor Xa Aptamer and Catalytic Site Inhibitors$36,720
F30 · FY2015 · HL · contact PI